Centene Corporation (CNC) - Q3 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2025. Centene Corporation is a leading healthcare enterprise providing managed care services primarily through government-sponsored programs (Medicaid, Medicare) and the Health Insurance Marketplace. The company operates four segments: Medicaid, Medicare, Commercial, and Other. As of September 30, 2025, total managed care membership was 28.0 million, a decrease of 2% year-over-year.
Key Financial Metrics
| Metric | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Total Revenues | $49.7 billion | $42.0 billion | $145.1 billion | $122.3 billion |
| Premium & Service Revenues | $44.9 billion | $36.9 billion | $129.9 billion | $109.2 billion |
| GAAP Net Earnings (Loss) | $(6.6) billion | $0.7 billion | $(5.6) billion | $3.0 billion |
| Adjusted Net Earnings | $0.2 billion | $0.8 billion | $1.6 billion | $3.3 billion |
| Diluted EPS (GAAP) | $(13.50) | $1.36 | $(11.29) | $5.69 |
| Adjusted Diluted EPS | $0.50 | $1.62 | $3.26 | $6.31 |
| Health Benefits Ratio (HBR) | 92.7% | 89.2% | 91.1% | 87.9% |
| SG&A Expense Ratio | 7.0% | 8.3% | 7.3% | 8.4% |
| Cash & Equivalents | $17.1 billion | $14.1 billion | $17.1 billion | $14.6 billion |
| Total Debt | $17.6 billion | $18.5 billion | $17.6 billion | $18.5 billion |
Material Changes vs. Prior Period
- Significant Impairment Charge: The company recorded a non-cash goodwill impairment of $6.7 billion in Q3 2025, driven by the passage of the "One Big Beautiful Bill Act" (OBBBA) in July 2025, potential membership impacts, and a decline in stock price. This charge resulted in a GAAP net loss of $6.6 billion for the quarter.
- Revenue Growth: Total revenues increased 18% year-over-year in Q3, driven by premium and membership growth in the Prescription Drug Plan (PDP) business, Marketplace growth, and Medicaid rate increases.
- Margin Pressure: The Health Benefits Ratio (HBR) deteriorated to 92.7% from 89.2% in the prior year. This was driven by increased medical costs in the Marketplace and Medicaid segments (behavioral health, home health, high-cost drugs) and lower estimated risk adjustment revenue.
- Membership Trends: Total membership declined 2% to 28.0 million. Medicaid membership decreased due to redeterminations, while Medicare Advantage membership declined 10% due to strategic positioning, though PDP membership grew 18%.
Guidance, Outlook, and Risks
- Regulatory Impact (OBBBA): The OBBBA introduces work requirements for Medicaid expansion, more frequent eligibility redeterminations, and cost-sharing provisions, potentially increasing morbidity and reducing federal funding starting in 2027-2028. It also restricts Advance Premium Tax Credits (APTCs) for Marketplace enrollees starting in 2026.
- Medicare Part D Changes: The Inflation Reduction Act (IRA) changes effective in 2025 shifted cost-sharing responsibilities, increasing premiums for PDPs but capping member out-of-pocket costs. A premium deficiency reserve of $282 million was recorded for the 2025 Medicare Advantage contract year.
- Outlook: Management expects to take corrective pricing actions for 2026 in states representing approximately 95% of Marketplace membership to reflect higher projected morbidity. The company anticipates continued membership declines in Medicaid due to redeterminations.
- Liquidity: The company maintains a strong liquidity position with $17.1 billion in cash and equivalents and $4.0 billion available under its Revolving Credit Facility. It has $1.8 billion remaining under its stock repurchase program.
- Legal Proceedings: A putative federal securities class action was filed in July 2025 alleging false statements regarding 2025 earnings guidance. The company denies wrongdoing and is vigorously defending the claims.
Key Facts for Investor Verification
- Impairment Drivers: Verify the specific actuarial assumptions and discount rates used in the $6.7 billion goodwill impairment analysis, particularly regarding the impact of the OBBBA on future cash flows.
- Medical Cost Trends: Monitor the trajectory of the Health Benefits Ratio (HBR) as the company navigates higher medical costs in Medicaid and Marketplace segments versus rate increases.
- Membership Redeterminations: Track the pace of Medicaid membership loss due to state redetermination processes and the potential impact of new work requirements under the OBBBA.
- Risk Adjustment Revenue: Assess the impact of lower estimated risk adjustment transfers on Commercial segment profitability, as noted in the reduction of 2025 earnings expectations.
- Legal Exposure: Follow the status of the securities class action lawsuit filed in July 2025 and any potential settlements or regulatory penalties.